1
|
Couffignal C, Kolta S, Flamant M, Cazanave C, Haymann JP, Mentré F, Duval X, Leport C, Raffi F, Chêne G, Salamon R, Moatti JP, Pierret J, Spire B, Brun-Vézinet F, Fleury H, Masquelier B, Peytavin G, Garraffo R, Costagliola D, Dellamonica P, Katlama C, Meyer L, Salmon D, Sobel A, Cuzin L, Dupon M, Le Moing V, Marchou B, May T, Morlat P, Rabaud C, Waldner-Combernoux A, Hardel L, Reboud P, Couffin-Cadiergues S, Marchand L, Assuied A, Carrieri P, Habak S, Couturier F, Jadand C, Perrier A, Préau M, Protopopescu C, Schmit J, Chennebault J, Faller J, Magy-Bertrand N, Chirouze C, Humbert P, Longy-Boursier, Neau D, Granier P, Ansart S, Verdon R, Merrien D, Chevojon P, Sobel A, Levy Y, Piroth L, Perronne C, Froguel E, Ceccaldi J, Chidiac C, Grégoire V, Reynes J, Fuzibet JG, Arsac P, Bouvet E, Bricaire F, Monsonego J, Girard P, Guillevin L, Herson S, Molina J, Pialoux G, Sain O, Sellier P, Roblot F, Bani-Sadr F, Michelet C, Lucht F, Debord C, Martin T, De Jaureguiberry J, Bernard L. Nevirapine Use Is Associated with Higher Bone Mineral Density in HIV-1 Positive Subjects on Long-Term Antiretroviral Therapy. AIDS Res Hum Retroviruses 2020; 36:399-405. [PMID: 31891665 DOI: 10.1089/aid.2019.0229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
We assessed bone mineral density (BMD) in a cohort of human immunodeficiency virus (HIV)-positive patients after a median of 11 years of combination antiretroviral therapy (cART) and evaluated the respective role of HIV infection and antiretroviral drugs (ARVs). A cross-sectional study of 162 participants (131 male) from the ANRS-C08 cohort was performed with bone dual-energy X-ray absorptiometry (DXA) scans and renal assessment. The window of exposure to ARVs was defined as an exposure of more than six cumulative months during the last 3 years before the DXA evaluation to account for a cumulative exposure that could affect bone remodeling. The association with low BMD (Z-score < -2) was assessed by a multiple logistic regression model. The study population was 50 years (median), hepatitis C virus (HCV) (18%), and hepatitis B virus (HBV) (8%) coinfection with HIV-RNA <50 c/mL in 89%, median CD4 of 619/mm3. Prevalence of low BMD was 18% in males and 6% in females. The factors associated with a Z-score < -2 in males were uric acid renal loss [adjusted odds ratio (aOR): 6.1; 95% confidence interval (CI): 1.2-31.5; p = .03], HCV coinfection (aOR: 4.0; 95% CI: 1.3-12.2; p = .02), and less frequent window of exposure to nevirapine (NVP) (aOR: 0.1; 95% CI: 0.02-0.6; p = .01). For the full study sample, there was a strong positive association between duration of exposure to NVP and lumbar spine Z-score (p = .004). HIV-positive patients exposed to long-term cART have a high incidence of low BMD. Tenofovir disoproxil fumarate and ritonavir-boosted protease inhibitors did not seem to be associated with increased risk of low BMD, whereas NVP exposure appeared to have an independent positive association.
Collapse
Affiliation(s)
- Camille Couffignal
- Infection, Antimicrobials, Modeling, Evolution (IAME) UMR 1137, INSERM and Université of Paris, Paris, France
| | - Sami Kolta
- Department of Rheumatology, University Hospital Cochin, Assistance Publique–Hôpitaux de Paris, INSERM UMR-1153, Paris, France
| | - Martin Flamant
- Department of Physiology, University Hospital Bichat, Assistance Publique–Hôpitaux de Paris, Paris, France
| | - Charles Cazanave
- Infectious Diseases Department, University Hospital Bordeaux, Bordeaux, France
| | - Jean-Philippe Haymann
- Department of Physiology, University Hospital Tenon, and INSERM UMR_S1155, Paris, France
| | - France Mentré
- Infection, Antimicrobials, Modeling, Evolution (IAME) UMR 1137, INSERM and Université of Paris, Paris, France
| | - Xavier Duval
- Infection, Antimicrobials, Modeling, Evolution (IAME) UMR 1137, INSERM and Université of Paris, Paris, and INSERM CIC1425, Paris, France
| | - Catherine Leport
- Unité COREB (Coordination du Risque Epidémique et Biologique), Assistance Publique–Hôpitaux de Paris, Paris, France
| | - François Raffi
- Infectious Diseases Department, University Hospital Hotel-Dieu, and INSERM CIC 1413, University of Nantes, Nantes, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Broussy S, Rouanet F, Lesaine E, Domecq S, Kret M, Maugeais M, Aly F, Dehail P, Bénard A, Wittwer J, Salamon R, Sibon I, Saillour-Glenisson F. Post-stroke pathway analysis and link with one year sequelae in a French cohort of stroke patients: the PAPASePA protocol study. BMC Health Serv Res 2019; 19:770. [PMID: 31665006 PMCID: PMC6820977 DOI: 10.1186/s12913-019-4522-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2019] [Accepted: 09/10/2019] [Indexed: 11/10/2022] Open
Abstract
Background Stroke is a health problem with serious consequences, both in terms of mortality, and after-effects affecting patient quality of life. Stroke requires both urgent and chronic management involving the entire health care system. Although large variability in the management of stroke patients have been noticed, knowledge of the diversity and the scalability of post-stroke pathways, whether it is the care pathway or the life pathway, is currently not sufficient. Moreover the link between post-stroke pathways and patients sequelae have not been yet clearly defined. All this information would be useful to better target the needs to improve stroke patient management. The purposes are to identify the post-stroke life pathways components associated with sequelae (activity limitations – main purpose, cognitive disorders, anxio-depressive disorders, fatigue, participation restrictions) at 3 months and 1 year post-stroke, to define a typology of life pathways of patients during the post-stroke year and to analyze the social and geographical inequalities in the management of stroke. Methods Design: a prospective multicenter comparative cohort study with a follow up to 1 year after the acute episode. Participant centers: 13 hospitals in the Aquitaine region (France). Study population: patients diagnosed with a confirmed ischemic or hemorrhagic stroke included in the Aquitaine Observatory of Stroke (ObA2) cohort and voluntary to participate. Data sources are existing databases (ObA2 database and the French National Health Data System - SNDS) to collect information about care pathways, patient characteristics and stroke characteristics and Ad hoc surveys to collect information about life pathways and post-stroke sequelae. The endpoints of the study are post-stroke activity limitations evaluated by the modified Rankin score, other post-stroke sequelae (Cognitive disorders, anxio-depressive disorders, fatigue, restriction of participation) assessed by standardized and validated scales and Clusters of patients responding to pathways with common or similar characteristics.; Discussion By integrating a longitudinal dimension and relying on a large cohort, the project will make it possible to identify the sources of disturbances and the factors favorable to the outcome of the life pathways, important for the planning of the offer and the management of the public policies concerning stroke pathways. Trial registration ClinicalTrials.gov ID: NCT03865173, March 6th, 2019.
Collapse
Affiliation(s)
- S Broussy
- Université de Bordeaux, Institut de Santé Publique d'Epidémiologie et de Développement, Centre INSERM U1219 Bordeaux Population Health center, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France. .,INSERM, ISPED, Centre INSERM U1219-Bordeaux Population Health, F-33000, Bordeaux, France.
| | - F Rouanet
- Pôle des Neurosciences Cliniques (I.S., F.R.) CHU Bordeaux, Bordeaux, France
| | - E Lesaine
- Université de Bordeaux, Institut de Santé Publique d'Epidémiologie et de Développement, Centre INSERM U1219 Bordeaux Population Health center, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France.,INSERM, ISPED, Centre INSERM U1219-Bordeaux Population Health, F-33000, Bordeaux, France
| | - S Domecq
- Université de Bordeaux, Institut de Santé Publique d'Epidémiologie et de Développement, Centre INSERM U1219 Bordeaux Population Health center, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France
| | - M Kret
- CHU de Bordeaux, Pôle de santé publique, Service d'Information Médicale, F-33000, Bordeaux, France
| | - M Maugeais
- Université de Bordeaux, Institut de Santé Publique d'Epidémiologie et de Développement, Centre INSERM U1219 Bordeaux Population Health center, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France
| | - F Aly
- Physical and Rehabilitation Medicine Unit, EA4136, Bordeaux University Hospital, University of Bordeaux, Bordeaux, France
| | - P Dehail
- Physical and Rehabilitation Medicine Unit, EA4136, Bordeaux University Hospital, University of Bordeaux, Bordeaux, France
| | - A Bénard
- Université de Bordeaux, Institut de Santé Publique d'Epidémiologie et de Développement, Centre INSERM U1219 Bordeaux Population Health center, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France.,INSERM, ISPED, Centre INSERM U1219-Bordeaux Population Health, F-33000, Bordeaux, France.,CHU de Bordeaux, Pôle de santé publique, Service d'Information Médicale, F-33000, Bordeaux, France
| | - J Wittwer
- Université de Bordeaux, Institut de Santé Publique d'Epidémiologie et de Développement, Centre INSERM U1219 Bordeaux Population Health center, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France.,INSERM, ISPED, Centre INSERM U1219-Bordeaux Population Health, F-33000, Bordeaux, France
| | - R Salamon
- Université de Bordeaux, Institut de Santé Publique d'Epidémiologie et de Développement, Centre INSERM U1219 Bordeaux Population Health center, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France.,INSERM, ISPED, Centre INSERM U1219-Bordeaux Population Health, F-33000, Bordeaux, France
| | - I Sibon
- Pôle des Neurosciences Cliniques (I.S., F.R.) CHU Bordeaux, Bordeaux, France.,Neurology, Stroke Unit, INCIA CNRS UMR 5287, Bordeaux University Hospital, University of Bordeaux, Bordeaux, France
| | - F Saillour-Glenisson
- Université de Bordeaux, Institut de Santé Publique d'Epidémiologie et de Développement, Centre INSERM U1219 Bordeaux Population Health center, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France.,INSERM, ISPED, Centre INSERM U1219-Bordeaux Population Health, F-33000, Bordeaux, France.,CHU de Bordeaux, Pôle de santé publique, Service d'Information Médicale, F-33000, Bordeaux, France
| |
Collapse
|
3
|
Pigoń K, Salamon R, Radzik E, Wołoszyn-Horák E, Płoszaj K, Nowalany-Kozielska E, Tomasik A. PO293 Frail Elderly Women Have the Highest Relative Wall Thickness In Comparison With Men and Non-Frail Patients. Glob Heart 2018. [DOI: 10.1016/j.gheart.2018.09.235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
4
|
Radzik E, Tomasik A, Pigoń K, Salamon R, Horák E, Płoszaj K, Stępień E, Kozielska E. PO141 Central Arterial Stiffness and Soluble Suppression of Tumorigenicity 2 In Frail Elderly Patients With Symptomatic Heart Disease. Glob Heart 2018. [DOI: 10.1016/j.gheart.2018.09.131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
5
|
Commenges D, Barberger-Gateau P, Dartigues JF, Loiseau P, Salamon R. A Non-homogeneous Markov Chain Model for Follow-up Studies with Application to Epilepsy. Methods Inf Med 2018. [DOI: 10.1055/s-0038-1635326] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
SummaryA non-homogeneous Markov chain model is proposed for diseases involving several pathological states. An estimator of the probability of being in a given state at a given time is presented together with an estimator of its variance. A method combining the Mantel-Haenszel and the sum of χ2 procedures enables us to test-whether two groups can be described by the same non-homogeneous Markov chain. Failure time data can be described by a system with two states, one being absorbing. In this case the proposed estimator reduces itself to the actuarial estimator and the test method to the logrank test. Applied to epilepsy this method is a useful tool for analysing the history of children suffering from typical absences (TA) and who can experience other forms of the disease such as grand mal (GM) and remission of TA or GM.
Collapse
|
6
|
Salamon R, Bernadet M, Samson M, Derouesne C, Gremy F. Bayesian Method Applied to Decision Making in Neurology — Methodological Considerations. Methods Inf Med 2018. [DOI: 10.1055/s-0038-1636671] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
This article presents an analysis of the method used in an experiment in computer-aided diagnosis, applied to the whole field of neurology.While the method is based on the classical Theorem of Bayes, it nevertheless contains a number of new elements:— By means of a self-learning procedure, it makes use of the patient sample as it grows in size;— there is an overall analysis of results as well as an individual analysis of each diagnosis.
Collapse
|
7
|
Jacqmin H, Commenges D, Barberger-Gateau P, Dartigues JF, Salamon R, Letenneur L. Cerebral and Functional Aging: First Results on Prevalence and Incidence of the Paquid Cohort. Methods Inf Med 2018. [DOI: 10.1055/s-0038-1634916] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Abstract:Paquid is an interdisciplinary study designed to investigate cerebral and functional aging. A cohort of 3,777 community residents living in two administrative areas of South-Western France was selected. A standardized questionnaire was administered at home by trained psychologists. The same procedure was applied one and three years after the baseline data collection. The identification of demented subjects was made with a two-step procedure. The first step is a systematic screening by the psychologists using the DSM-III criteria for dementia. Subjects who fulfilled the DSM-III criteria were examined by a neurologist. Diagnosis of dementia is confirmed according to the NINCDS-ADRDA criteria. The Paquid cohort is complemented by a random sample of 357 institutionalized subjects. First results of prevalence and incidence rates show an exponential increase of dementia with age.
Collapse
|
8
|
Galéra C, Salla J, Montagni I, Hanne-Poujade S, Salamon R, Grondin O, Guichard E, Bouvard MP, Tzourio C, Michel G. Stress, attention deficit hyperactivity disorder (ADHD) symptoms and tobacco smoking: The i-Share study. Eur Psychiatry 2017; 45:221-226. [PMID: 28957791 DOI: 10.1016/j.eurpsy.2017.07.007] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/15/2017] [Revised: 07/17/2017] [Accepted: 07/18/2017] [Indexed: 10/19/2022] Open
Abstract
BACKGROUND The contribution of mental health to the risk of smoking is increasingly acknowledged but still insufficiently studied during the key period of student life. In particular, the simultaneous action of stress and Attention Deficit Hyperactivity Disorder (ADHD) symptoms on the risk of smoking remains poorly understood. AIMS To assess the effects of stress and ADHD symptoms on tobacco smoking. METHOD Multivariate modeling was conducted on the French i-Share study (n=8110, median age 20.3 years, 74.8% females, 32.9% regular/occasional smokers) to evaluate the associations between stress, ADHD symptoms and tobacco smoking, adjusting for potential family/socio-demographic confounders. RESULTS Students with high levels of stress were more likely to smoke>10 cigarettes/day (adjusted odds ratio (aOR): 1.48, 95% CI: 1.12-1.96) than those with low levels of stress. Students with high levels of ADHD symptoms were more likely to smoke>10 cigarettes/day (aOR: 2.08, 95% CI: 1.58-2.75) than those with low levels of ADHD symptoms. CONCLUSIONS Stress and ADHD contribute independently to the risk of smoking. Interventions targeting each condition are likely to reduce the burden of tobacco use in students.
Collapse
Affiliation(s)
- C Galéra
- UMR1219, université de Bordeaux, 33000 Bordeaux, France; UMR1219, Inserm, HEALTHY Team, 33000 Bordeaux, France; Centre hospitalier Perrens, 33076 Bordeaux, France.
| | - J Salla
- UMR1219, université de Bordeaux, 33000 Bordeaux, France; UMR1219, Inserm, HEALTHY Team, 33000 Bordeaux, France
| | - I Montagni
- UMR1219, université de Bordeaux, 33000 Bordeaux, France; UMR1219, Inserm, HEALTHY Team, 33000 Bordeaux, France
| | - S Hanne-Poujade
- UMR1219, université de Bordeaux, 33000 Bordeaux, France; UMR1219, Inserm, HEALTHY Team, 33000 Bordeaux, France
| | - R Salamon
- UMR1219, université de Bordeaux, 33000 Bordeaux, France; UMR1219, Inserm, HEALTHY Team, 33000 Bordeaux, France
| | - O Grondin
- UMR1219, université de Bordeaux, 33000 Bordeaux, France; UMR1219, Inserm, HEALTHY Team, 33000 Bordeaux, France
| | - E Guichard
- Inserm CIC1415, CHRU de Tours, 37044 Tours, France
| | - M P Bouvard
- UMR1219, université de Bordeaux, 33000 Bordeaux, France; Centre hospitalier Perrens, 33076 Bordeaux, France
| | - C Tzourio
- UMR1219, université de Bordeaux, 33000 Bordeaux, France; UMR1219, Inserm, HEALTHY Team, 33000 Bordeaux, France
| | - G Michel
- UMR1219, université de Bordeaux, 33000 Bordeaux, France; UMR1219, Inserm, HEALTHY Team, 33000 Bordeaux, France
| |
Collapse
|
9
|
De Maricourt P, Gorwood P, Hergueta T, Galinowski A, Salamon R, Diallo A, Vaugeois C, Lépine JP, Olié JP, Dubois O. Balneotherapy Together with a Psychoeducation Program for Benzodiazepine Withdrawal: A Feasibility Study. Evid Based Complement Alternat Med 2016; 2016:8961709. [PMID: 27956923 PMCID: PMC5124454 DOI: 10.1155/2016/8961709] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/23/2016] [Accepted: 10/11/2016] [Indexed: 11/21/2022]
Abstract
Benzodiazepines should be prescribed on a short-term basis, but a significant proportion of patients (%) use them for more than 6 months, constituting a serious public health issue. Indeed, few strategies are effective in helping patients to discontinue long-term benzodiazepine treatments. The aim of this study was to assess the feasibility and the impact of a program including cognitive behavioural therapy, psychoeducation, and balneotherapy in a spa resort to facilitate long-term discontinuation of benzodiazepines. We conducted a prospective multicentre cohort study. Patients with long-term benzodiazepine use were recruited with the aim of anxiolytic withdrawal by means of a psychoeducational program and daily balneotherapy during 3 weeks. The primary efficacy outcome measure was benzodiazepine use 6 months after the program, compared to use at baseline. A total of 70 subjects were enrolled. At 6 months, overall benzodiazepine intake had decreased by 75.3%, with 41.4% of patients completely stopping benzodiazepine use. The results also suggest a significantly greater improvement in anxiety and depression symptoms among patients who discontinued benzodiazepines compared to patients who only reduced their use. Our findings suggest that balneotherapy in association with a psychoeducative program is efficient in subjects with benzodiazepine addiction.
Collapse
Affiliation(s)
- P. De Maricourt
- Service Hospitalo Universitaire de Santé Mentale et de Thérapeutique, Université Paris Descartes, Centre Hospitalier Sainte Anne, Paris, France
- INSERM UMR 894, PRES Sorbonne Centre de Psychiatrie et Neurosciences, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - P. Gorwood
- INSERM UMR 894, PRES Sorbonne Centre de Psychiatrie et Neurosciences, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Th. Hergueta
- Laboratoire de Psychopathologie et Processus de Santé (EA 4057), Institut de Psychologie, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - A. Galinowski
- Service Hospitalo Universitaire de Santé Mentale et de Thérapeutique, Université Paris Descartes, Centre Hospitalier Sainte Anne, Paris, France
| | - R. Salamon
- Institute of Public Health, Epidemiology and Development “ISPED”, Bordeaux University, Bordeaux, France
| | - A. Diallo
- Institute of Public Health, Epidemiology and Development “ISPED”, Bordeaux University, Bordeaux, France
| | - C. Vaugeois
- Le Manoir Clinic, 09400 Ussat les Bains, France
| | - J. P. Lépine
- APHP, Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Vidal, Paris, France
| | - J. P. Olié
- Service Hospitalo Universitaire de Santé Mentale et de Thérapeutique, Université Paris Descartes, Centre Hospitalier Sainte Anne, Paris, France
- INSERM UMR 894, PRES Sorbonne Centre de Psychiatrie et Neurosciences, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - O. Dubois
- Saujon Clinic, BP 30, 17600 Saujon, France
| |
Collapse
|
10
|
Broussy S, Lesaine E, Rouanet F, Maugeais M, Salamon R, Saillour-Glenisson F. Quantification des séquelles fonctionnelles chez les patients ayant présenté un accident vasculaire cérébral. Rev Epidemiol Sante Publique 2016. [DOI: 10.1016/j.respe.2016.06.073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
11
|
Degoulet P, Fieschi M, Goldberg M, Salamon R. François Grémy, a humanist and information sciences pioneer. Yearb Med Inform 2014; 9:3-5. [PMID: 25123715 PMCID: PMC4287063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023] Open
|
12
|
|
13
|
Seri B, Inwoley A, Gabillard D, Messou E, Eholie S, Salamon R, Tessier JF, Ménan H, Seyler C, Anglaret X. Incidence de la séroconversion de la toxoplasmose chez des adultes infectés par le VIH à Abidjan, Côte d’Ivoire. Rev Epidemiol Sante Publique 2013. [DOI: 10.1016/j.respe.2013.07.282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
14
|
Le Goaster C, Peretti-Watel P, Salamon R. Éditorial. Rev Epidemiol Sante Publique 2013. [DOI: 10.1016/j.respe.2013.07.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
15
|
Colombani F, Pereira E, Bettaieb J, Gobin L, Cowppli-Bony A, Hoppe S, Coureau G, Picat M, Salamon R, Monnereau A, Savès M. Intérêt des données du registre hospitalier (Enquête permanente cancer) d’un centre régional de lutte contre le cancer pour un registre de cancer en population. Rev Epidemiol Sante Publique 2013; 61:1-9. [DOI: 10.1016/j.respe.2012.04.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2011] [Revised: 03/07/2012] [Accepted: 04/25/2012] [Indexed: 11/17/2022] Open
|
16
|
Berraho M, Bendahhou K, Abda N, Mathoulin-Pelissier S, Salamon R, Nejjari C. Les facteurs associés au retard de diagnostic du cancer du col au Maroc. Rev Epidemiol Sante Publique 2012. [DOI: 10.1016/j.respe.2012.06.147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
17
|
Bourdillon F, Lakhdar CB, Salamon R. [Tobacco: the taxation is also a tool of public health]. Rev Epidemiol Sante Publique 2012; 60:79-80. [PMID: 22464404 DOI: 10.1016/j.respe.2012.03.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2012] [Accepted: 03/12/2012] [Indexed: 11/16/2022] Open
|
18
|
Houinato DS, Gbary AR, Houehanou YC, Djrolo F, Amoussou M, Segnon-Agueh J, Kpozehouen A, Salamon R. Prevalence of hypertension and associated risk factors in Benin. Rev Epidemiol Sante Publique 2012; 60:95-102. [PMID: 22436411 DOI: 10.1016/j.respe.2011.09.010] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2010] [Revised: 08/12/2011] [Accepted: 09/07/2011] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND Hypertension is one of the main risk factors of cardiovascular diseases. There has been a lack of data on this risk factor in the general population in Benin. The aim of this study was to determine the prevalence of hypertension and identify the associated risk factors in Benin. METHODS A cross-sectional study was conducted from July to August 2008 in Benin's 12 departments. The questionnaire and anthropometric measurements of the World Health Organization STEPWISE survey were used. The sample included 6853 subjects 25-64 years of age, randomly selected by five-stage random sampling. Blood pressure was measured using standard procedures. Data was processed and analyzed using EPI DATA and STATA 9.2 software. Prevalence levels were compared using Pearson's chi(2) and means with the Student t-test. Univariate and multivariate regression analysis, taking the sampling method into account, was used to identify risk factors. RESULTS The sample comprised 49.5% females, the 25- to 34-year-old age group was the largest, and the mean age was 42.7±12.4 years. The prevalence of hypertension was 27.9% [95% CI: 26.3-29.5%], 77.5% of the subjects were unaware of their high blood pressure, and 81.6% had not taken their drugs two weeks before the survey. Prevalence of known hypertension was 6.9%, prevalence of treated hypertension 4.8%, and prevalence of controlled hypertension 1.9%. Age and obesity were significantly associated with hypertension. Department and profession were not associated with hypertension. CONCLUSION This study showed a high prevalence of hypertension in the general population in Benin. Better management of this risk factor will contribute to reducing morbidity and mortality due to cardiovascular diseases.
Collapse
Affiliation(s)
- D S Houinato
- Université d'Abomey Calavi, 01 BP 526, Cotonou, Bénin.
| | | | | | | | | | | | | | | |
Collapse
|
19
|
Dubois O, Vaugeois C, Salamon R. Prise en charge psycho éducative pour sevrage de benzodiazépines en cure thermale. Encephale 2011. [DOI: 10.1016/s0013-7006(11)70010-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
20
|
Masquelier B, Taieb A, Reigadas S, Marchou B, Cheneau C, Spire B, Charpentier C, Leport C, Raffi F, Chene G, Descamps D, Leport C, Raffi F, Chene G, Salamon R, Moatti JP, Pierret J, Spire B, Brun-Vezinet F, Fleury H, Masquelier B, Peytavin G, Garraffo R, Costagliola D, Dellamonica P, Katlama C, Meyer L, Salmon D, Sobel A, Cuzin L, Dupon M, Duval X, Le Moing V, Marchou B, May T, Morlat P, Rabaud C, Waldner-Combernoux A, Reboud P, Couffin-Cadiergues S, Marchand L, Bouteloup V, Bouhnik AD, Brunet-Francois C, Caron V, Carrieri MP, Courcoul M, Couturier F, Hardel L, Iordache L, Kurkdji P, Martiren S, Preau M, Protopopescu C, Surzyn J, Taieb A, Villes V, Schmit JL, Chennebault JM, Faller JP, Mgy-Bertrand N, Hoen B, Drobachef, Bouchaud O, Dupon M, Longy-Boursier, Morlat P, Ragnaud JM, Granier P, Garre M, Verdon R, Merrien D, Devidas A, Sobel A, Piroth L, Perronne C, Froguel E, Ceccaldi J, Peyramond D, Allard C, Reynes J, May T, Raffi F, Fuzibet JG, Dellamonica P, Arsac P, Bouvet E, Bricaire F, Bergmann P, Cabane J, Monsonego J, Girard PM, Guillevin L, Herson S, Leport C, Meyohas MC, Molina JM, Pialoux G, Salmon D, Roblot P, Jaussaud R, Michelet C, Lucht F, Debord T, Rey D, De Jaureguiberry JP, Marchou B, Bernard L. Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy. J Antimicrob Chemother 2011; 66:1582-9. [DOI: 10.1093/jac/dkr153] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
|
21
|
Vivot A, Colombani F, Trouette H, Colonna M, Fournier E, Leux C, Coureau G, Salamon R, Savès M, Nicolescu-Catargi B. R128 – Oral Surincidence des carcinomes thyroïdiens en Gironde : comparaison de la taille des tumeurs entre différents registres de cancer français. Bull Cancer 2010. [DOI: 10.1016/s0007-4551(15)31048-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
22
|
Gilleron V, Kostrzewa A, Barat C, Palmer V, de Pommerol M, Salamon R. Quels domaines d’application pour l’analyse des données issues de la base du PMSI ? Méthode de classement retenue au CHU de Bordeaux. Rev Epidemiol Sante Publique 2010. [DOI: 10.1016/j.respe.2010.02.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
23
|
Quantin C, Salamon R, Toussaint E, Fieschi M. Avant-propos. Rev Epidemiol Sante Publique 2010; 58 Suppl 1:S3-37. [DOI: 10.1016/j.respe.2010.02.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
24
|
Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V, Tattevin P, Iung B, Delahaye F, Alla F, Leport C, Beguinot I, Bouvet A, Briancon S, Bruneval P, Danchin N, Etienne J, Goulet V, Mainardi JL, Roudaut R, Ruimy R, Salamon R, Texier-Maugein J, Vandenesch F, Bernard Y, Duchene F, Plesiat P, Doco-Lecompte T, Selton-Suty C, Weber M, Beguinot I, Nazeyrollas P, Vernet V, Garin B, Lacassin F, Robert J, Andremont A, Garbaz E, Le Moing V, Leport C, Mainardi JL, Ruimy R, Chidiac C, Delahaye F, Etienne J, Vandenesch F, Boucherit S, Bourezane Y, Nouioua W, Renaud D, Bouvet A, Collobert G, Merad B, Schlegel L, Bes M, Etienne J, Vandenesch F. The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J 2009; 32:2003-15. [DOI: 10.1093/eurheartj/ehp008] [Citation(s) in RCA: 129] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
25
|
Bouche G, Migeot V, Mathoulin-Pélissier S, Salamon R, Ingrand P. Breast cancer surgery: Do all patients want to go to high-volume hospitals? J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.6636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
26
|
Bénard A, Petersen E, Salamon R, Chêne G, Gilbert R, Salmi LR. Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. ACTA ACUST UNITED AC 2008; 13. [PMID: 18445459 DOI: 10.2807/ese.13.15.18834-en] [Citation(s) in RCA: 52] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The objective of this investigation was to describe systems for the epidemiological surveillance of congenital toxoplasmosis implemented in European countries. In September 2004, a questionnaire, adapted from the evaluation criteria published by the United States Centers for Disease Control and Prevention, was sent to a panel of national correspondents in 35 countries in the European geographical area with knowledge of the epidemiological surveillance systems implemented in their countries. Where necessary, we updated the information until July 2007. Responses were received from 28 countries. Some 16 countries reported routine surveillance for toxoplasmosis. In 12 countries (Bulgaria, Cyprus, Czech Republic, England and Wales, Estonia, Ireland, Latvia, Lithuania, Malta, Poland, Scotland and Slovakia), surveillance was designed to detect only symptomatic toxoplasmosis, whether congenital or not. Four countries reported surveillance of congenital toxoplasmosis, on a regional basis in Italy and on a national basis in Denmark, France and Germany. In conclusion, epidemiological surveillance of congenital toxoplasmosis needs to be improved in order to determine the true burden of disease and to assess the effectiveness of and the need for existing prevention programmes.
Collapse
Affiliation(s)
- A Bénard
- Institut national de la santé et de la recherche médicale (National institute of health and medical research, INSERM), U897, Bordeaux, France.
| | | | | | | | | | | | | |
Collapse
|
27
|
Avillach P, Savès M, Thiessard F, Gilleron V, Hajjar M, Barat C, Colombani F, Salamon R. Outil d’identification des cas non incidents de tumeurs malignes de la prostate pour un registre de cancer à partir des données du PMSI. Rev Epidemiol Sante Publique 2008. [DOI: 10.1016/j.respe.2008.02.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
28
|
Gilleron V, Barat C, Kostrzewa A, Salmi L, Salamon R. Utilisation des données issues du PMSI dans le cadre des autres réformes hospitalières que la T2A. Rev Epidemiol Sante Publique 2008. [DOI: 10.1016/j.respe.2008.02.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
29
|
Bricout H, Gilleron V, Salamon R. Intérêt de l’utilisation des données médicales du PMSI dans le domaine de l’épidémiologie. Rev Epidemiol Sante Publique 2008. [DOI: 10.1016/j.respe.2008.02.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
30
|
Ettorchi A, Hajjar M, Salamon R. PMSI et évaluation des objectifs de santé publique. Rev Epidemiol Sante Publique 2008. [DOI: 10.1016/j.respe.2008.02.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
31
|
Salamon R. Modalités d’évaluation de l’hydrothérapie : étude STOP-TAG. Encephale 2007. [DOI: 10.1016/s0013-7006(07)92083-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
32
|
Breton G, Lewden C, Spire B, Salmon D, Brun-Vézinet F, Duong M, Allavena C, Leport C, Salamon R. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France. HIV Med 2007; 8:164-70. [PMID: 17461860 DOI: 10.1111/j.1468-1293.2007.00447.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
BACKGROUND The world-wide AIDS epidemic is reflected in Western Europe in an increasing number of HIV-infected persons who originate from Africa. We describe the characteristics and response to antiretroviral therapy (ART) of HIV-infected patients born in Africa and living in France. METHODS Analysis of data from the (Anti PROtéase COhorte APROCO) cohort study of HIV-infected patients initiating ART was carried out. Included in the study were 90 patients born in sub-Saharan Africa, 53 in North Africa and 771 in metropolitan France. RESULTS At baseline, there was a higher proportion of women and of the heterosexual transmission route of infection among patients born in sub-Saharan Africa, a higher proportion of injecting drug users among patients born in North Africa and a higher frequency of unemployment and of unstable housing conditions among patients born in both sub-Saharan and North Africa as compared with patients born in France. The median CD4 cell count was lower in patients born in both sub-Saharan and North Africa (sub-Saharan Africa: 197 cells/microL; North Africa: 222 cells/microL) than in patients born in France (307 cells/microL). Median HIV-1 viral loads were similar. After a median follow-up time of 36 months (2506 patient-years), the Kaplan-Meier estimations of probability of survival without new AIDS-defining events were not different. After 36 months of ART, in multivariate analysis, median CD4 cell count, CD4/CD8 ratio and viral load were not statistically different according to birthplace, but the median CD4 percentage was lower in patients born in both sub-Saharan and North Africa. The adherence profiles were similar. CONCLUSIONS Although clinical response and adherence to ART did not appear to differ in patients according to their birthplace, the reasons for the more advanced HIV infection observed at ART initiation among patients born in Africa should be further investigated.
Collapse
Affiliation(s)
- G Breton
- Service de Maladies Infectieuses et Tropicales B, CHU Bichat, Université Paris VII, Paris, France
| | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Quantin C, Guinot C, Tursz A, Salomez JL, Rogier C, Salamon R. [Should epidemiological data be extracted from personal medical files?]. Rev Epidemiol Sante Publique 2006; 54:177-84. [PMID: 16830972 DOI: 10.1016/s0398-7620(06)76711-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
34
|
Bricout H, Gilleron V, Barat C, Colombani F, Salmi L, Savès M, Salamon R. E1-2 - Apport et limites de l’utilisation des données médicales issues du Programme de Médicalisation des Systèmes d’Information dans une démarche épidémiologique appliquée au cancer. Rev Epidemiol Sante Publique 2006. [DOI: 10.1016/s0398-7620(06)76853-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
35
|
Salmi L, Suissa S, Chêne G, Salamon R. E4-6 - Mesure de l’efficacité des actions de santé et notion d’effet atteint. Rev Epidemiol Sante Publique 2006. [DOI: 10.1016/s0398-7620(06)76874-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
36
|
Defossez G, Mathoulin-Pélissier S, Mériau N, Lapeyrère N, Ingrand I, Migeot V, Salamon R. B3-3 - Mesure de la satisfaction de patientes atteintes de cancer du sein non métastasé en population française : développement et premières étapes de validation du REPERES-CSS-VF60. Rev Epidemiol Sante Publique 2006. [DOI: 10.1016/s0398-7620(06)76804-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
37
|
Losina E, Anglaret X, Yazdanpanah Y, Wang B, Toure S, Seage GR, N'Dri-Yoman T, Walensky RP, Dakoury-Dogbo N, Goldie SJ, Messou E, Weinstein MC, Deuffic-Burban S, Salamon R, Freedberg KA. Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire. S Afr Med J 2006; 96:526-9. [PMID: 16841136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/10/2023] Open
Abstract
OBJECTIVE To estimate incidence rates of opportunistic diseases (ODs) and mortality for patients with and without a history of OD among HIV-infected patients in Côte d'Ivoire. METHODS Using incidence density analysis, we estimated rates of ODs and chronic mortality by CD4 count in patients in a cotrimoxazole prophylaxis trial in Abidjan before the highly active antiretroviral therapy (HAART) era. Chronic mortality was defined as death without a history of OD or death more than 30 days after an OD diagnosis. We used Poisson's regression to examine the effect of OD history on chronic mortality after adjusting for age, gender, and current CD4 count. RESULTS Two hundred and seventy patients (40% male, mean age 33 years, median baseline CD4 count 261 cells/microl) were followed up for a median of 9.5 months. Bacterial infections and tuberculosis were the most common severe ODs. Of 47 patients who died, 9 (19%) died within 30 days of an OD, 26 (55%) died more than 30 days after an OD, and 12 (26%) died with no OD history. The chronic mortality rate was 31.0/100 person-years for those with an OD history, and 11.1/100 person-years for those with no OD history (rate ratio (RR) 2.81, 95% confidence interval (CI): 1.43 - 5.54). Multivariate analysis revealed that OD history remained an independent predictor of mortality (RR 2.15, 95% CI: 1.07 - 4.33) after adjusting for CD4 count, age and gender. CONCLUSIONS Before the HAART era, a history of OD was associated with increased chronic HIV mortality in Côte d'Ivoire, even after adjusting for CD4 count. These results provide further evidence supporting OD prophylaxis in HIV-infected patients.
Collapse
Affiliation(s)
- E Losina
- Departments of Biostatistics and Epidemiology, School of Public Health, Boston University, Boston, MA, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Bensefa L, Causse E, Verret C, Choudat D, Brochard P, Jutand M, Salamon R, Conso F. Enquête française sur la Guerre du Golfe et ses conséquences sur la santé : resultants du bilan médical réalisé chez 1 008 vétérans. ARCH MAL PROF ENVIRO 2006. [DOI: 10.1016/s1775-8785(06)78182-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
39
|
Salamon R, Verret C, Jutand MA, Bégassat M, Laoudj F, Conso F, Brochard P. Health consequences of the first Persian Gulf War on French troops. Int J Epidemiol 2006; 35:479-87. [PMID: 16434429 DOI: 10.1093/ije/dyi318] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Since 1993, many studies on the health of Persian Gulf War Veterans (PGWV) have been undertaken. These studies have concluded that there has been an increased mortality due to external causes, no excess of recognized diseases, and no effect on PGWV children. When compared with the non-deployed, PGWV have reported a higher frequency of infertility as well as different symptoms, but a specific Gulf War syndrome was not identified. In October 2000, the French government asked an independent working group to analyse the scientific literature on PGWV health. The group concluded that an exhaustive study of French PGWV was to be undertaken. The objectives of this study were to describe the exposures of PGWV in the operations theatre, to report on the symptoms and diseases that occurred in PGWV and their children during and after the military campaign, and to explore the possibility of a Gulf War syndrome. This exhaustive cross-sectional study, which included all civilians and troops who served in the Gulf from August 1990 to July 1991, began in January 2002. Data were collected by postal self-administered questionnaires. A standardized clinical evaluation was performed by 27 clinics of occupational diseases and nine military hospitals. Symptoms and diseases which appeared after the campaign are described. To date, among 20,261 PGWV, 5,666 participated in the study (28%). The most frequent symptoms described since the return from the Gulf were headaches (83%), neurological or psychological symptoms, and back pain. Apart from well-known symptoms associations (respiratory, neurocognitive, psychological and musculo-skeletal syndromes), no other cluster was highlighted by our analysis.
Collapse
Affiliation(s)
- R Salamon
- Department of Epidemiology, Public Health and Development, INSERM U593, Victor Segalen University Bordeaux 2, Bordeaux, France.
| | | | | | | | | | | | | |
Collapse
|
40
|
Moty-Monnereau C, Leroy V, Deligne J, Latapy C, Rumeau-Pichon C, Blum-Boisgard C, Flori YA, Salamon R. Dépistage prénatal du cytomégalovirus en France : une augmentation des pratiques de prescription de 2000 à 2003 malgré l’absence de recommandation favorable. Rev Epidemiol Sante Publique 2005; 53:591-600. [PMID: 16434932 DOI: 10.1016/s0398-7620(05)84739-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
Abstract
BACKGROUND Screening cytomegalovirus infection in pregnant women is still controversial in 2004 in France. In this context, we evaluated the interest of such a screening in 2004 in France. This paper was designed to describe trends in CMV prenatal screening practices in 2000-2003 in France. METHODS This retrospective study, describes the prescription of CMV screening in HIV-negative pregnant women giving birth in the private care sector, according to their occupational category and geographical area. Data were provided by the "Caisse d'Assurance-maladie des Travailleurs Indépendants" (independent workers health insurance fund). RESULTS The study included 34.347 women, delivering in 2001-2004 (beginning of pregnancy in 2000-2003). The number of pregnant women screened for CMV increased significantly between 2000 (5.8%, 301/5.177), 2001 (11.1%, 1.130/10.139) and 2002 (22.1%, 2.701/12.223), (p<0.001), then was stable in 2003 (22.0%, 1.496/6.808). The percentage of women screened for CMV, at least once during pregnancy, doubled between 2001 and 2002 (p<0.001) in each occupational category and geographical area. It was significantly different between occupational categories (p<0.01), with a higher percentage of women in the self-employed and commercial agent occupational categories than in the craftsman category. There was also a significant difference between geographical areas (p<0.001), with a higher rate in Paris. CONCLUSION This study providing baseline information on CMV practices showed: 1- a significant increase in the frequency of CMV screening among pregnant women over the period 2000-2002 with a stabilization in 2003; 2- a similar trend observed in each occupation category and geographical area but with a markedly higher frequency of screening practices in the Paris area and among self-employed women. A study measuring the effect of the 2004 ANAES recommendation suggesting not to screen for CMV during pregnancy should be conducted.
Collapse
|
41
|
Minga AK, Huët C, Coulibaly I, Abo Y, Dohoun L, Bonard D, Gourvellec G, Coulibaly Y, Konaté S, Dabis F, Bondurand A, Salamon R. [Profile of HIV infected patients among blood donors in Abidjan, Côte d'Ivoire (1992-1999)]. Bull Soc Pathol Exot 2005; 98:123-6. [PMID: 16050380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
Abstract
The FonSIDA is a private clinic created in 1992 within the premises of the National Blood Transfusion Center of Abidjan (CNTS), the largest city in Côte d'Ivoire. It provides medical and psychological follow-up for blood donors which are diagnosed as HIV-infected. This Centre provides blood for transfusions in Abidjan and the surrounding area, which from 1992 to 1999 collected 263,398 blood units. In this period, 5574 subjects were detected HIV-positive. Among those, 1766 (32%) HIV infected blood donors came back to be tested for confirmation of HIV diagnosis. Since then, only 9% of the 5574 donors have been seen at least twice a year for medical and psychological follow-up. Women were more compliant than men in the FonSIDA Clinic: they constituted 62% of the 409 patients who were followed-up (p < 0.001). 53% of men had sex with prostitutes the year before HIV diagnosis. 67% of women stated voluntary abortion at least once. In the same period the systematic use of condoms was reported by only 7% of women and 5% of men. 22% of women and 28% of men reported having two or more sexual partners in the year before HIV diagnosis. The main aim of every blood center is to improve blood safety, particularly in developing countries. The appropriate counseling towards blood donors and especially those detected HIV positive can contribute to reduce new HIV infections in high HIV prevalence cities. Rate of compliance of HIV-infected patients to follow-up has risen to 11% in 1992-1994 to 60% in 1997-1999 and will contribute to reach this aim.
Collapse
Affiliation(s)
- A K Minga
- Projet ANRS 1220, Programme PAC-CI, Abidjan, Côte d'Ivoire.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Bonnet F, Thiébaut R, Chêne G, Neau D, Pellegrin JL, Mercié P, Beylot J, Dabis F, Salamon R, Morlat P. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002. HIV Med 2005; 6:198-205. [PMID: 15876287 DOI: 10.1111/j.1468-1293.2005.00290.x] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
OBJECTIVES To determine the factors associated with clinical progression (AIDS events and death) in antiretroviral-naive patients who have begun highly active antiretroviral therapy (HAART). METHODS HIV-infected patients naive to antiretroviral therapy were included in a prospective hospital-based cohort who began HAART between June 1996 and December 2001. Progression was explained by baseline characteristics using Cox proportional hazards models. RESULTS Overall, data for 709 patients were analysed. In multivariate analysis, factors associated with an increased risk of progression were CD4 count < 50 cells/microL [hazard ratio (HR) = 13.0 (95% confidence interval 3.8-44.3)] and between 50 and 199 cells/microL [HR = 5.1 (1.6-16.3)], when compared with patients with CD4 count>350 cells/microL; AIDS events before HAART prescription [HR = 2.1 (1.2-3.7)]; CD8 count < 400 cells/microL [HR = 1.8 (1.1-3.0)]; and older age (HR = 1.2 by 10 years (1.0-1.5)]. In a second model including CD4 percentage, factors associated with progression were CD4 < 10% [HR = 6.3 (2.2-17.9)] and 10%<CD4 < 15% [HR = 4.2 (1.4-12.5)], when compared with patients with CD4 > 20%; CD8 count; AIDS events before HAART prescription; and older age. In a third model including the CD4:CD8 ratio, factors associated with progression were CD4:CD8 < 15% [HR = 8.2 (2.3-28.8)] and 15% < CD4:CD8 < 30% [HR = 4.6 (1.3-16.0)], when compared with patients with CD4:CD8 > 45%; AIDS events before HAART prescription; and older age. The Akaike information criteria for model analysis were 803, 805 and 815, respectively. CONCLUSIONS Consideration of CD4 level in terms of CD4:CD8 ratio or CD4 percentage can be a good alternative to absolute CD4 count. Other prognostic factors such as older age, CD8 count < 400 cells/microL and AIDS events also have to be considered in the decision to initiate HAART.
Collapse
Affiliation(s)
- F Bonnet
- Department of Internal Medicine and Infectious Diseases, Saint-André Hospital, Bordeaux University Hospital, Bordeaux, France.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Moty C, Leroy V, Latapy C, Rumeau-Pichon C, Deligne J, Salamon R. C4-6 Évolution des pratiques de dépistage du cytomégalovirus chez la femme enceinte en France, 2001-2002. Rev Epidemiol Sante Publique 2004. [DOI: 10.1016/s0398-7620(04)99173-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022] Open
|
44
|
Gilleron V, Fiore M, Salmi L, Barat C, Salamon R. P5-10 Démarche d’amélioration de la qualité du codage PMSI des séjours de cancérologie au CHU de Bordeaux. Rev Epidemiol Sante Publique 2004. [DOI: 10.1016/s0398-7620(04)99274-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
45
|
Gourvellec G, Anglaret X, Touré S, Huët C, Dakoury-Dogbo N, Lafont S, N'Dri-Yoman T, Chêne G, Salamon R. [Compliance in HIV infected adults. Study of opportunistic infection prophylaxis with cotrimoxazole in Ivory Coast]. Presse Med 2004; 33:595-600. [PMID: 15226691 DOI: 10.1016/s0755-4982(04)98683-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
Abstract
BACKGROUND The compliance to a daily treatment for illimited duration and the factors that influence it have been rarely studied in sub-Saharian Africa. OBJECTIVE Describe the compliance to prophylaxis with cotrimoxazole fort (one tablet per day) and its associated factors in patients infected by HIV participating in a clinical trial in Abidjan. METHOD The tablets packed in individual blisters were provided every month, and the blisters were recuperated the following month. A global compliance ratio (GCR) was established for each patient (empty blisters at the end of the study/follow-up period during the study) and monthly compliance ratio [MCR] (empty blisters during a visit/time lapse since last visit). For each monthly visit foreseen in the protocol, a respect of the appointment ratio (RAR) was described (visits foreseen in the protocol respected that month/visits foreseen in the protocol). The association of GCR with the characteristics on inclusion was studied using logistic regression methods. RESULTS 530 adults were followed-up for a mean of 10 months. The MCR and the RAR progressed in parallel, decreasing the first 5 months and stabilizing at around 0.80 for the RAR and 0.70 for the MCR. The mean GCR was of 0.77. Three hundred and nine patients (58%) were considered as compliant (0.80<GCR<1). In multivariate analysis, those belonging to the group of compliers were associated with a paid occupation and with a past of tuberculosis, and was not associated with age, gender, level of education, nationality, civil status, number of persons in the home, proximity of a care center, clinical grade or CD4. DISCUSSION The estimated compliance was correct and stable. The association with a history of tuberculosis suggests that a person having already followed prolonged daily treatment would be more readily compliant to other long term treatments. CONCLUSION In Africa, cotrimoxazole is initiated long before the stage of antiretroviral treatment. The concern regarding the efficacy of such prophylaxis raises the question of compliance early on in the disease. This prepares the teams that organise the management of such patients to being faced with the problems of compliance to antiretrovirals.
Collapse
|
46
|
Bonard D, Rouet F, Toni TA, Minga A, Huet C, Ekouévi DK, Dabis F, Salamon R, Rouzioux C. Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Côte d'Ivoire, West Africa. J Acquir Immune Defic Syndr 2003; 34:267-73. [PMID: 14600570 DOI: 10.1097/00126334-200311010-00002] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
The aim of this study was to evaluate the heat-dissociated p24 antigen (HD p24 Ag) assay as an alternative low-cost tool for diagnosis of HIV-1 infection and quantitation of HIV-1 RNA levels in African adults mainly infected with HIV-1 CRF02_AG strains. One hundred seventeen plasma specimens were obtained from HIV-1-seropositive subjects enrolled in the ANRS 1220 PRIMO-CI cohort (Abidjan, Côte d'Ivoire, West Africa). Results of the HD p24 Ag assay were comparable with those of HIV-1 RNA levels quantified in the same antibody-positive plasma samples by the Amplicor HIV-1 Monitor assay (1.5 version; Roche Diagnostics, Indianapolis, IN): sensitivity, 95.7% versus 96.6%, respectively; specificity (evaluated with samples from 75 seronegative subjects), 94.7% versus 100%, respectively. HD p24 Ag and HIV-1 RNA assays were weakly correlated (Spearman coefficient correlation, r = 0.33; P < 0.001) except for HIV-1 RNA levels of >/=5 log10 copies/mL (r = 0.62; P < 0.001). Quantitation of HD p24 antigenemia in 76 plasma specimens from 14 patients treated with highly active antiretroviral therapy demonstrated weaker changes during treatment than those observed with the HIV-1 RNA assay. Follow-up of infected patients using both markers showed different results. The reliability of the HD p24 Ag assay is questionable for clinical and biologic management as a surrogate tool for measurement of HIV-1 RNA levels in Africa.
Collapse
Affiliation(s)
- D Bonard
- Centre de Diagnostic et de Recherches sur le SIDA, CHU de Treichville, BP V3 Abidjan, Côte d'Ivoire, West Africa.
| | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Bonnet F, Thiébaut R, Chêne G, Neau D, Pellegrin J, Ceccaldi J, Mercié P, Beylot J, Dabis F, Salamon R, Morlat P, GECSA. La valeur absolue des lymphocytes CD4+ n'est pas le seul paramètre à considérer pour initier une multithérapie antirétrovirale (MARV) chez les sujets infectés par le VIH : étude de cohorte de 709 patients. Rev Med Interne 2003. [DOI: 10.1016/s0248-8663(03)80409-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
48
|
Abstract
In Lebanon, childhood asthma is an important disease and pesticides are commonly used. The objective of this study was to evaluate whether exposure to pesticides has chronic effects on the respiratory health of Lebanese children. A cross-sectional study was performed on children from a randomly selected sample of Lebanese public schools. Exposure to pesticides was evaluated by a standardised questionnaire and a residential exposure score, and respiratory symptoms were assessed by using the American Thoracic Society standardised questionnaire. A chronic respiratory disease was reported in 407 (12.4%) out of 3,291 children. The baseline difference in mean age was small but statistically significant. Any exposure to pesticides, including residential, para-occupational and domestic, was associated with respiratory disease and chronic respiratory symptoms (chronic phlegm, chronic wheezing, ever wheezing), except for chronic cough. Exposure to pesticides was associated with chronic respiratory symptoms and disease among Lebanese children.
Collapse
Affiliation(s)
- P R Salameh
- Faculty of Public Health, Lebanese University, Fanar, Lebanon.
| | | | | | | | | | | |
Collapse
|
49
|
Rabarijaona LP, Boisier P, Ravaoalimalala VE, Jeanne I, Roux JF, Jutand MA, Salamon R. Lot quality assurance sampling for screening communities hyperendemic for Schistosoma mansoni. Trop Med Int Health 2003; 8:322-8. [PMID: 12667151 DOI: 10.1046/j.1365-3156.2003.01019.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Lot quality assurance sampling (LQAS) was evaluated for rapid low cost identification of communities where Schistosoma mansoni infection was hyperendemic in southern Madagascar. In the study area, S. mansoni infection shows very focused and heterogeneous distribution requiring multifariousness of local surveys. One sampling plan was tested in the field with schoolchildren and several others were simulated in the laboratory. Randomization and stool specimen collection were performed by voluntary teachers under direct supervision of the study staff and no significant problem occurred. As expected from Receiver Operating Characteristic (ROC) curves, all sampling plans allowed correct identification of hyperendemic communities and of most of the hypoendemic ones. Frequent misclassifications occurred for communities with intermediate prevalence and the cheapest plans had very low specificity. The study confirmed that LQAS would be a valuable tool for large scale screening in a country with scarce financial and staff resources. Involving teachers, appeared to be quite feasible and should not lower the reliability of surveys. We recommend that the national schistosomiasis control programme systematically uses LQAS for identification of communities, provided that sample sizes are adapted to the specific epidemiological patterns of S. mansoni infection in the main regions.
Collapse
Affiliation(s)
- L P Rabarijaona
- Unité d'Epidémiologie, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
| | | | | | | | | | | | | |
Collapse
|
50
|
Yazdanpanah Y, Goldie SJ, Paltiel AD, Losina E, Coudeville L, Weinstein MC, Gerard Y, Kimmel AD, Zhang H, Salamon R, Mouton Y, Freedberg KA. Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis. Clin Infect Dis 2003; 36:86-96. [PMID: 12491207 DOI: 10.1086/344902] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2002] [Accepted: 09/17/2002] [Indexed: 11/03/2022] Open
Abstract
A simulation model of human immunodeficiency virus (HIV) disease, which incorporated French data on the progression of HIV disease in the absence of antiretroviral therapy and on cost, was used to determine the clinical impact and cost-effectiveness of different strategies for the prevention of opportunistic infections in French patients who receive highly active antiretroviral therapy (HAART). Compared with use of no prophylaxis, use of trimethoprim-sulfamethoxazole (TMP-SMZ) increased per-person lifetime costs from euro 185,600 to euro 187,900 and quality-adjusted life expectancy from 112.2 to 113.7 months, for an incremental cost-effectiveness ratio of euro 18,700 per quality-adjusted life-year (euro/QALY) gained. Compared with use of TMP-SMZ alone, use of TMP-SMZ plus azithromycin cost euro 23,900/QALY gained; adding fluconazole cost an additional euro 54,500/QALY gained. All strategies that included oral ganciclovir had cost-effectiveness ratios that exceeded euro 100,000/QALY gained. In the era of HAART, on the basis of French data, prophylaxis against Pneumocystis carinii pneumonia, toxoplasmic encephalitis, and Mycobacterium avium complex bacteremia is cost-effective. Prophylaxis against fungal and cytomegalovirus infections is less cost-effective than are other therapeutic options for HIV disease and should remain of lower priority.
Collapse
Affiliation(s)
- Y Yazdanpanah
- Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Faculté de Médecine de Lille, Lille, France.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|